Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-050467

Ovid Therapeutics Inc. · OVID

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jeremy M Levin
Officer — CEO · Director · 10% Owner
Period of report
Aug 25, 2017
Accepted (ET)
Aug 28, 2017 · 6:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001636651

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Aug 25, 2017P15,334$7.15A4,601,529D
Common StockF2holding———35,461ISee Footnote
Common StockF3holding———465,116ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses